Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1513622

Cover Image

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1513622

Next Generation IV Infusion Pumps Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

PUBLISHED:
PAGES: 350 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 6400
PDF (Corporate User License)
USD 7400

Add to Cart

Persistence Market Research has recently released a comprehensive report on the worldwide market for next generation IV infusion pumps. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Next Generation IV Infusion Pumps Market Size (2024E): USD 3.1 Billion
  • Projected Market Value (2033F): USD 5.8 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 7.2%

Next Generation IV Infusion Pumps Market - Report Scope:

Next generation IV infusion pumps are essential for the precise delivery of medications, fluids, and nutrients directly into a patient's bloodstream. These advanced pumps incorporate features such as wireless connectivity, integration with electronic health records (EHRs), and smart alarm systems to enhance safety and efficiency. The market serves hospitals, outpatient clinics, homecare settings, and ambulatory surgical centers, offering a variety of pump types, including large volume pumps, syringe pumps, and ambulatory pumps.

Market Growth Drivers:

The global next generation IV infusion pumps market is propelled by several key factors, including the increasing prevalence of chronic diseases, which drives the demand for advanced infusion therapy. The growing aging population and rising incidence of hospital-acquired infections (HAIs) further fuel market expansion. Technological advancements, such as the development of smart infusion pumps with enhanced safety features, promote market growth by improving treatment accuracy and patient outcomes. Additionally, the shift towards home-based healthcare and outpatient care supports the adoption of portable and user-friendly infusion devices.

Market Restraints:

Despite promising growth prospects, the next generation IV infusion pumps market faces challenges related to regulatory compliance, high device costs, and the risk of technical malfunctions. Stringent regulations governing the manufacturing, marketing, and use of infusion pumps impose compliance burdens on manufacturers, affecting market entry barriers and operational costs. Furthermore, the high cost of advanced infusion systems and concerns about potential device failures or errors pose challenges for market penetration, particularly in resource-constrained settings. Addressing these regulatory and economic barriers requires collaboration between industry stakeholders and policymakers to ensure access to safe and affordable infusion solutions.

Market Opportunities:

The next generation IV infusion pumps market presents significant growth opportunities driven by technological innovations, healthcare infrastructure improvements, and evolving patient care models. The integration of digital health technologies, such as remote monitoring and telehealth platforms, enhances patient access to infusion therapy and improves treatment adherence and outcomes. Additionally, the expanding application of infusion pumps beyond traditional healthcare settings, including in emergency medical services and military medicine, broadens the market scope. Strategic partnerships, investment in research and development, and the introduction of cost-effective and user-friendly infusion solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic healthcare landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the next generation IV infusion pumps market globally?
  • Which pump types and applications are driving infusion pump adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the next generation IV infusion pumps market?
  • Who are the key players contributing to the next generation IV infusion pumps market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global next generation IV infusion pumps market?

Competitive Intelligence and Business Strategy:

Leading players in the global next generation IV infusion pumps market, including Baxter International Inc., B. Braun Melsungen AG, and ICU Medical, Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced infusion solutions, including wireless-enabled pumps, integration with hospital information systems, and portable infusion devices, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving infusion therapy landscape.

Key Companies Profiled:

  • Gamastech S.R.L
  • Ambu A/S
  • Summit Medical Products, Inc.
  • Nipro Corporation
  • Terumo Corporation
  • Medtronic Plc.
  • Zyno Medical
  • Baxter International Inc.
  • Fresenius Kabi AG
  • B. Braun Melsungen AG
  • Becton, Dickinson Company (CareFusion)
  • Smith's Medical (Smiths Group plc.)
  • Hospira Inc.
  • iRadimed Corporation
  • vTitan

Key Segments Covered in Next-Generation IV Infusion Pumps Industry Research

Type of Pumps:

  • Large Volumetric Infusion Systems
  • Syringe Infusion Systems
  • Electronic-Ambulatory Infusion Systems
  • Patient Controlled Analgesia Pumps
  • Disposable Elastomeric Infusion Systems
  • Implantable Infusion Systems
  • MRI-Compatible IV Infusion Systems
  • IV Disposables

Application:

  • Clinical Nutrition
  • Pain Management
  • Chemotherapy
  • Antibiotic Management

End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Diagnostic Centers

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa
Product Code: PMRREP15781

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Brand Share/Preference of Equipment Installed
  • 4.2. New Product Launches
  • 4.3. Regulatory Scenario
  • 4.4. Reimbursement Landscape
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis
  • 4.7. Value Chain Analysis
  • 4.8. Key Promotional Strategies by Manufacturers

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Injectable Drug Delivery Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. Technological Advancements in Next Generation IV Infusion Pumps
    • 5.2.3. New Product Launches
    • 5.2.4. Cost of Products
    • 5.2.5. Rising Cardiac Diseases
    • 5.2.6. Growing Adoption Rate
    • 5.2.7. Strategic Mergers and Acquisitions Among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue By Type of Pumps
    • 6.1.2. Revenue By Application
    • 6.1.3. Revenue By End User
    • 6.1.4. Revenue By Region
  • 6.2. 2024 Market Scenario

7. Global Next Generation IV Infusion Pumps Market Demand Volume Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Next Generation IV Infusion Pumps Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By-Type of Pumps
  • 8.2. Pricing Break Up
    • 8.2.1. Manufacturer Level
    • 8.2.2. Distributor Level
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Next Generation IV Infusion Pumps Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Type of Pumps

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Type of Pumps, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Type of Pumps, 2024-2033
    • 10.3.1. Large Volumetric Infusion Systems
    • 10.3.2. Syringe Infusion Systems
    • 10.3.3. Electronic-Ambulatory Infusion Systems
    • 10.3.4. Patient Controlled Analgesia Pumps
    • 10.3.5. Disposable Elastomeric Infusion Systems
    • 10.3.6. Implantable Infusion Systems
    • 10.3.7. MRI-Compatible IV Infusion Systems
    • 10.3.8. IV Disposables
  • 10.4. Market Attractiveness Analysis By Type of Pumps

11. Global Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033, by Application

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
    • 11.3.1. Clinical Nutrition
    • 11.3.2. Pain Management
    • 11.3.3. Chemotherapy
    • 11.3.4. Antibiotic Management
    • 11.3.5. Others
  • 11.4. Market Attractiveness Analysis By Application

12. Global Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033, by End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Ambulatory Surgical Centers
    • 12.3.3. Homecare Settings
    • 12.3.4. Diagnostic Centers
    • 12.3.5. Others
  • 12.4. Market Attractiveness Analysis By End User

13. Global Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 14.4.1. By Country
      • 14.4.1.1. U.S.
      • 14.4.1.2. Canada
    • 14.4.2. By Type of Pumps
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Type of Pumps
    • 14.5.3. By Application
    • 14.5.4. By End User
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Market Trends
  • 14.9. Country Level Analysis & Forecast
    • 14.9.1. U.S. Next Generation IV Infusion Pumps Market
      • 14.9.1.1. Introduction
      • 14.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.9.1.2.1. By Type of Pumps
        • 14.9.1.2.2. By Application
        • 14.9.1.2.3. By End User
    • 14.9.2. Canada Next Generation IV Infusion Pumps Market
      • 14.9.2.1. Introduction
      • 14.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.9.2.2.1. By Type of Pumps
        • 14.9.2.2.2. By Application
        • 14.9.2.2.3. By End User

15. Latin America Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 15.4.1. By Country
      • 15.4.1.1. Brazil
      • 15.4.1.2. Mexico
      • 15.4.1.3. Argentina
      • 15.4.1.4. Rest of Latin America
    • 15.4.2. By Type of Pumps
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Type of Pumps
    • 15.5.3. By Application
    • 15.5.4. By End User
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Market Trends
  • 15.9. Country Level Analysis & Forecast
    • 15.9.1. Brazil Next Generation IV Infusion Pumps Market
      • 15.9.1.1. Introduction
      • 15.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.9.1.2.1. By Type of Pumps
        • 15.9.1.2.2. By Application
        • 15.9.1.2.3. By End User
    • 15.9.2. Argentina Next Generation IV Infusion Pumps Market
      • 15.9.2.1. Introduction
      • 15.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.9.2.2.1. By Type of Pumps
        • 15.9.2.2.2. By Application
        • 15.9.2.2.3. By End User
    • 15.9.3. Mexico Next Generation IV Infusion Pumps Market
      • 15.9.3.1. Introduction
      • 15.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.9.3.2.1. By Type of Pumps
        • 15.9.3.2.2. By Application
        • 15.9.3.2.3. By End User

16. Europe Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 16.4.1. By Country
      • 16.4.1.1. Germany
      • 16.4.1.2. Italy
      • 16.4.1.3. France
      • 16.4.1.4. U.K.
      • 16.4.1.5. Spain
      • 16.4.1.6. BENELUX
      • 16.4.1.7. Russia
      • 16.4.1.8. Rest of Europe
    • 16.4.2. By Type of Pumps
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Type of Pumps
    • 16.5.3. By Application
    • 16.5.4. By End User
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Market Trends
  • 16.9. Country Level Analysis & Forecast
    • 16.9.1. Germany Next Generation IV Infusion Pumps Market
      • 16.9.1.1. Introduction
      • 16.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.1.2.1. By Type of Pumps
        • 16.9.1.2.2. By Application
        • 16.9.1.2.3. By End User
    • 16.9.2. France Next Generation IV Infusion Pumps Market
      • 16.9.2.1. Introduction
      • 16.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.2.2.1. By Type of Pumps
        • 16.9.2.2.2. By Application
        • 16.9.2.2.3. By End User
    • 16.9.3. Italy Next Generation IV Infusion Pumps Market
      • 16.9.3.1. Introduction
      • 16.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.3.2.1. By Type of Pumps
        • 16.9.3.2.2. By Application
        • 16.9.3.2.3. By End User
    • 16.9.4. Spain Next Generation IV Infusion Pumps Market
      • 16.9.4.1. Introduction
      • 16.9.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.4.2.1. By Type of Pumps
        • 16.9.4.2.2. By Application
        • 16.9.4.2.3. By End User
    • 16.9.5. U.K. Next Generation IV Infusion Pumps Market
      • 16.9.5.1. Introduction
      • 16.9.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.5.2.1. By Type of Pumps
        • 16.9.5.2.2. By Application
        • 16.9.5.2.3. By End User
    • 16.9.6. BENELUX Next Generation IV Infusion Pumps Market
      • 16.9.6.1. Introduction
      • 16.9.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.6.2.1. By Type of Pumps
        • 16.9.6.2.2. By Application
        • 16.9.6.2.3. By End User
    • 16.9.7. Russia Next Generation IV Infusion Pumps Market
      • 16.9.7.1. Introduction
      • 16.9.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.7.2.1. By Type of Pumps
        • 16.9.7.2.2. By Application
        • 16.9.7.2.3. By End User

17. South Asia Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 17.4.1. By Country
      • 17.4.1.1. India
      • 17.4.1.2. Thailand
      • 17.4.1.3. Indonesia
      • 17.4.1.4. Malaysia
      • 17.4.1.5. Rest of South Asia
    • 17.4.2. By Type of Pumps
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Type of Pumps
    • 17.5.3. By Application
    • 17.5.4. By End User
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Market Trends
  • 17.9. Country Level Analysis & Forecast
    • 17.9.1. India Next Generation IV Infusion Pumps Market
      • 17.9.1.1. Introduction
      • 17.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.9.1.2.1. By Type of Pumps
        • 17.9.1.2.2. By Application
        • 17.9.1.2.3. By End User
    • 17.9.2. Indonesia Next Generation IV Infusion Pumps Market
      • 17.9.2.1. Introduction
      • 17.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.9.2.2.1. By Type of Pumps
        • 17.9.2.2.2. By Application
        • 17.9.2.2.3. By End User
    • 17.9.3. Malaysia Next Generation IV Infusion Pumps Market
      • 17.9.3.1. Introduction
      • 17.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.9.3.2.1. By Type of Pumps
        • 17.9.3.2.2. By Application
        • 17.9.3.2.3. By End User
    • 17.9.4. Thailand Next Generation IV Infusion Pumps Market
      • 17.9.4.1. Introduction
      • 17.9.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.9.4.2.1. By Type of Pumps
        • 17.9.4.2.2. By Application
        • 17.9.4.2.3. By End User

18. East Asia Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 18.4.1. By Country
      • 18.4.1.1. China
      • 18.4.1.2. Japan
      • 18.4.1.3. South Korea
    • 18.4.2. By Type of Pumps
    • 18.4.3. By Application
    • 18.4.4. By End User
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Type of Pumps
    • 18.5.3. By Application
    • 18.5.4. By End User
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Market Trends
  • 18.9. Country Level Analysis & Forecast
    • 18.9.1. China Next Generation IV Infusion Pumps Market
      • 18.9.1.1. Introduction
      • 18.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.9.1.2.1. By Type of Pumps
        • 18.9.1.2.2. By Application
        • 18.9.1.2.3. By End User
    • 18.9.2. Japan Next Generation IV Infusion Pumps Market
      • 18.9.2.1. Introduction
      • 18.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.9.2.2.1. By Type of Pumps
        • 18.9.2.2.2. By Application
        • 18.9.2.2.3. By End User
    • 18.9.3. South Korea Next Generation IV Infusion Pumps Market
      • 18.9.3.1. Introduction
      • 18.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.9.3.2.1. By Type of Pumps
        • 18.9.3.2.2. By Application
        • 18.9.3.2.3. By End User

19. Oceania Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Pricing Analysis
  • 19.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 19.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 19.4.1. By Country
      • 19.4.1.1. Australia
      • 19.4.1.2. New Zealand
    • 19.4.2. By Type of Pumps
    • 19.4.3. By Application
    • 19.4.4. By End User
  • 19.5. Market Attractiveness Analysis
    • 19.5.1. By Country
    • 19.5.2. By Type of Pumps
    • 19.5.3. By Application
    • 19.5.4. By End User
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Market Trends
  • 19.9. Country Level Analysis & Forecast
    • 19.9.1. Australia Next Generation IV Infusion Pumps Market
      • 19.9.1.1. Introduction
      • 19.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.9.1.2.1. By Type of Pumps
        • 19.9.1.2.2. By Application
        • 19.9.1.2.3. By End User
    • 19.9.2. New Zealand Next Generation IV Infusion Pumps Market
      • 19.9.2.1. Introduction
      • 19.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.9.2.2.1. By Type of Pumps
        • 19.9.2.2.2. By Application
        • 19.9.2.2.3. By End User

20. Middle East and Africa (MEA) Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Pricing Analysis
  • 20.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 20.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 20.4.1. By Country
      • 20.4.1.1. GCC Countries
      • 20.4.1.2. Turkey
      • 20.4.1.3. North Africa
      • 20.4.1.4. South Africa
      • 20.4.1.5. Rest of Middle East and Africa
    • 20.4.2. By Type of Pumps
    • 20.4.3. By Application
    • 20.4.4. By End User
  • 20.5. Market Attractiveness Analysis
    • 20.5.1. By Country
    • 20.5.2. By Type of Pumps
    • 20.5.3. By Application
    • 20.5.4. By End User
  • 20.6. Key Market Participants - Intensity Mapping
  • 20.7. Drivers and Restraints - Impact Analysis
  • 20.8. Market Trends
  • 20.9. Country Level Analysis & Forecast
    • 20.9.1. GCC Countries Next Generation IV Infusion Pumps Market
      • 20.9.1.1. Introduction
      • 20.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.9.1.2.1. By Type of Pumps
        • 20.9.1.2.2. By Application
        • 20.9.1.2.3. By End User
    • 20.9.2. Turkey Next Generation IV Infusion Pumps Market
      • 20.9.2.1. Introduction
      • 20.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.9.2.2.1. By Type of Pumps
        • 20.9.2.2.2. By Application
        • 20.9.2.2.3. By End User
    • 20.9.3. North Africa Next Generation IV Infusion Pumps Market
      • 20.9.3.1. Introduction
      • 20.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.9.3.2.1. By Type of Pumps
        • 20.9.3.2.2. By Application
        • 20.9.3.2.3. By End User
    • 20.9.4. South Africa Next Generation IV Infusion Pumps Market
      • 20.9.4.1. Introduction
      • 20.9.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.9.4.2.1. By Type of Pumps
        • 20.9.4.2.2. By Application
        • 20.9.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Concentration
  • 21.4. Market Presence Analysis
    • 21.4.1. Regional Footprint Analysis
    • 21.4.2. Product Footprint Analysis
    • 21.4.3. Channel Footprint Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Gamastech S.R.L
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Key Financials
      • 22.3.1.4. SWOT Analysis
      • 22.3.1.5. Sales Footprint
      • 22.3.1.6. Strategy Overview
      • 22.3.1.7. Key Developments
        • 22.3.1.7.1. Marketing Strategies
        • 22.3.1.7.2. Product Strategies
        • 22.3.1.7.3. Channel Strategies
    • 22.3.2. Ambu A/S
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Key Financials
      • 22.3.2.4. SWOT Analysis
      • 22.3.2.5. Sales Footprint
      • 22.3.2.6. Strategy Overview
      • 22.3.2.7. Key Developments
        • 22.3.2.7.1. Marketing Strategies
        • 22.3.2.7.2. Product Strategies
        • 22.3.2.7.3. Channel Strategies
    • 22.3.3. Summit Medical Products, Inc.
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Key Financials
      • 22.3.3.4. SWOT Analysis
      • 22.3.3.5. Sales Footprint
      • 22.3.3.6. Strategy Overview
      • 22.3.3.7. Key Developments
        • 22.3.3.7.1. Marketing Strategies
        • 22.3.3.7.2. Product Strategies
        • 22.3.3.7.3. Channel Strategies
    • 22.3.4. Nipro Corporation
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Key Financials
      • 22.3.4.4. SWOT Analysis
      • 22.3.4.5. Sales Footprint
      • 22.3.4.6. Strategy Overview
      • 22.3.4.7. Key Developments
        • 22.3.4.7.1. Marketing Strategies
        • 22.3.4.7.2. Product Strategies
        • 22.3.4.7.3. Channel Strategies
    • 22.3.5. Terumo Corporation
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Key Financials
      • 22.3.5.4. SWOT Analysis
      • 22.3.5.5. Sales Footprint
      • 22.3.5.6. Strategy Overview
      • 22.3.5.7. Key Developments
        • 22.3.5.7.1. Marketing Strategies
        • 22.3.5.7.2. Product Strategies
        • 22.3.5.7.3. Channel Strategies
    • 22.3.6. Medtronic Plc.
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Key Financials
      • 22.3.6.4. SWOT Analysis
      • 22.3.6.5. Sales Footprint
      • 22.3.6.6. Strategy Overview
      • 22.3.6.7. Key Developments
        • 22.3.6.7.1. Marketing Strategies
        • 22.3.6.7.2. Product Strategies
        • 22.3.6.7.3. Channel Strategies
    • 22.3.7. Zyno Medical
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Key Financials
      • 22.3.7.4. SWOT Analysis
      • 22.3.7.5. Sales Footprint
      • 22.3.7.6. Strategy Overview
      • 22.3.7.7. Key Developments
        • 22.3.7.7.1. Marketing Strategies
        • 22.3.7.7.2. Product Strategies
        • 22.3.7.7.3. Channel Strategies
    • 22.3.8. Baxter International Inc.
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Key Financials
      • 22.3.8.4. SWOT Analysis
      • 22.3.8.5. Sales Footprint
      • 22.3.8.6. Strategy Overview
      • 22.3.8.7. Key Developments
        • 22.3.8.7.1. Marketing Strategies
        • 22.3.8.7.2. Product Strategies
        • 22.3.8.7.3. Channel Strategies
    • 22.3.9. Fresenius Kabi AG
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Key Financials
      • 22.3.9.4. SWOT Analysis
      • 22.3.9.5. Sales Footprint
      • 22.3.9.6. Strategy Overview
      • 22.3.9.7. Key Developments
        • 22.3.9.7.1. Marketing Strategies
        • 22.3.9.7.2. Product Strategies
        • 22.3.9.7.3. Channel Strategies
    • 22.3.10. B. Braun Melsungen AG
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Key Financials
      • 22.3.10.4. SWOT Analysis
      • 22.3.10.5. Sales Footprint
      • 22.3.10.6. Strategy Overview
      • 22.3.10.7. Key Developments
        • 22.3.10.7.1. Marketing Strategies
        • 22.3.10.7.2. Product Strategies
        • 22.3.10.7.3. Channel Strategies
    • 22.3.11. Becton, Dickinson Company (CareFusion)
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Key Financials
      • 22.3.11.4. SWOT Analysis
      • 22.3.11.5. Sales Footprint
      • 22.3.11.6. Strategy Overview
      • 22.3.11.7. Key Developments
        • 22.3.11.7.1. Marketing Strategies
        • 22.3.11.7.2. Product Strategies
        • 22.3.11.7.3. Channel Strategies
    • 22.3.12. Smiths Medical (Smiths Group plc.)
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Key Financials
      • 22.3.12.4. SWOT Analysis
      • 22.3.12.5. Sales Footprint
      • 22.3.12.6. Strategy Overview
      • 22.3.12.7. Key Developments
        • 22.3.12.7.1. Marketing Strategies
        • 22.3.12.7.2. Product Strategies
        • 22.3.12.7.3. Channel Strategies
    • 22.3.13. Hospira Inc.
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Key Financials
      • 22.3.13.4. SWOT Analysis
      • 22.3.13.5. Sales Footprint
      • 22.3.13.6. Strategy Overview
      • 22.3.13.7. Key Developments
        • 22.3.13.7.1. Marketing Strategies
        • 22.3.13.7.2. Product Strategies
        • 22.3.13.7.3. Channel Strategies
    • 22.3.14. iRadimed Corporation
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Key Financials
      • 22.3.14.4. SWOT Analysis
      • 22.3.14.5. Sales Footprint
      • 22.3.14.6. Strategy Overview
      • 22.3.14.7. Key Developments
        • 22.3.14.7.1. Marketing Strategies
        • 22.3.14.7.2. Product Strategies
        • 22.3.14.7.3. Channel Strategies
    • 22.3.15. vTitan
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Key Financials
      • 22.3.15.4. SWOT Analysis
      • 22.3.15.5. Sales Footprint
      • 22.3.15.6. Strategy Overview
      • 22.3.15.7. Key Developments
        • 22.3.15.7.1. Marketing Strategies
        • 22.3.15.7.2. Product Strategies
        • 22.3.15.7.3. Channel Strategies

23. Assumptions and Acronyms Used

24. Research Methodology

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!